Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elahe Taki

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pakistan Journal of Pharmaceutical Sciences|July 10, 2016
Efficacy of methanolic extract of green and black teas against extended-spectrum β-Lactamase-producing Pseudomonas aeruginosaArezou Taherpour, Ali Hashemi, Soroor Erfanimanesh, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|July 5, 2018
Prevalence of metallo-β-lactamase-encoding genes among carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in IranFereshteh Jabalameli, Elahe Taki, Mohammad Emaneini, et al.
Journal of Clinical Laboratory Analysis|November 29, 2025
The Role of Viral and Bacterial Infections in the Etiology of Behçet's DiseaseMohsen Moghoofei, Hamid Pajavand, Razieh Shahbazi, et al.
Expert Review of Anti-Infective Therapy|May 21, 2022
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIVElahe Taki, Faezeh Soleimani, Arezoo Asadi, et al.
Frontiers in Pharmacology|March 27, 2023
Ebanga™: The most recent FDA-approved drug for treating EbolaElahe Taki, Roya Ghanavati, Tahereh Navidifar, et al.
Journal of Clinical Laboratory Analysis|January 23, 2024
Periodontal disease in down syndrome: Predisposing factors and potential non-surgical therapeutic approachesMahdie Ghaffarpour, Morteza Karami-Zarandi, Hossein Ali Rahdar, et al.
Frontiers in Microbiology|September 4, 2024
Oral microbiota and metabolites: key players in oral health and disorder, and microbiota-based therapiesNarjess Bostanghadiri, Mobina Kouhzad, Elahe Taki, et al.
Antimicrobial Resistance and Infection Control|February 28, 2024
Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysisNarjess Bostanghadiri, Negar Narimisa, Maryam Mirshekar, et al.
Frontiers in Oncology|February 13, 2025
Carcinogenic and anticancer activities of microbiota-derived secondary bile acidsMobina Kouhzad, Friedrich Götz, Tahereh Navidifar, et al.
Journal of Clinical Laboratory Analysis|April 21, 2022
Mechanism of action, resistance, synergism, and clinical implications of azithromycinMohsen Heidary, Ahmad Ebrahimi Samangani, Abolfazl Kargari, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pakistan Journal of Pharmaceutical Sciences|July 10, 2016
Efficacy of methanolic extract of green and black teas against extended-spectrum β-Lactamase-producing Pseudomonas aeruginosaArezou Taherpour, Ali Hashemi, Soroor Erfanimanesh, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|July 5, 2018
Prevalence of metallo-β-lactamase-encoding genes among carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in IranFereshteh Jabalameli, Elahe Taki, Mohammad Emaneini, et al.
Journal of Clinical Laboratory Analysis|November 29, 2025
The Role of Viral and Bacterial Infections in the Etiology of Behçet's DiseaseMohsen Moghoofei, Hamid Pajavand, Razieh Shahbazi, et al.
Expert Review of Anti-Infective Therapy|May 21, 2022
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIVElahe Taki, Faezeh Soleimani, Arezoo Asadi, et al.
Frontiers in Pharmacology|March 27, 2023
Ebanga™: The most recent FDA-approved drug for treating EbolaElahe Taki, Roya Ghanavati, Tahereh Navidifar, et al.
Journal of Clinical Laboratory Analysis|January 23, 2024
Periodontal disease in down syndrome: Predisposing factors and potential non-surgical therapeutic approachesMahdie Ghaffarpour, Morteza Karami-Zarandi, Hossein Ali Rahdar, et al.
Frontiers in Microbiology|September 4, 2024
Oral microbiota and metabolites: key players in oral health and disorder, and microbiota-based therapiesNarjess Bostanghadiri, Mobina Kouhzad, Elahe Taki, et al.
Antimicrobial Resistance and Infection Control|February 28, 2024
Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysisNarjess Bostanghadiri, Negar Narimisa, Maryam Mirshekar, et al.
Frontiers in Oncology|February 13, 2025
Carcinogenic and anticancer activities of microbiota-derived secondary bile acidsMobina Kouhzad, Friedrich Götz, Tahereh Navidifar, et al.
Journal of Clinical Laboratory Analysis|April 21, 2022
Mechanism of action, resistance, synergism, and clinical implications of azithromycinMohsen Heidary, Ahmad Ebrahimi Samangani, Abolfazl Kargari, et al.
Pageof 2